{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-027357","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.334532+00:00","generated_at":"2026-06-11T21:31:07.880172+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Nephros Q2 2023 revenue $3.5M (+24% YoY); net loss narrows to $0.4M","bullets":["Net revenue $3.5M, up 24% from $2.9M in Q2 2022.","Net loss from continuing ops narrowed to $0.4M from $0.7M; adjusted EBITDA loss $0.2M vs $0.4M.","Gross margins improved to 59% from 49%; active customer sites up 6% to 1,427.","Cash and equivalents $4.1M as of June 30, 2023; maintained positive cash flow.","Cost of goods sold flat at $1.5M; SG&A increased to $2.2M from $1.9M."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-027357","json":"https://secwatch.observer/filing/0001493152-23-027357.json","markdown":"https://secwatch.observer/filing/0001493152-23-027357.md","text":"https://secwatch.observer/filing/0001493152-23-027357.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223027357/0001493152-23-027357-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223027357/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T21:31:07.880172+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8dd5c1ad513376a7e581705c043044a6272fd3cd","claim":"NEPHROS INC reported the second quarter ended June 30, 2023 results: revenue $3.5 million, net income $0.4 million.","evidence_excerpt":"Exhibit 99.1 Nephros, Inc. 380 Lackawanna Place South 201 343 5202 nephros.com Nephros Announces Results for Quarter Ended June 30, 2023 Second-Quarter Net Revenue of $3.5 Million, a 24% Increase Over 2022; Year-to-Date Revenue Increases 45%; Maintains Positive Cash Flow Results SOUTH ORANGE, NJ, August 9, 2023 – Nephros, Inc. (Nasdaq: NEPH), a leading","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223027357/0001493152-23-027357-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter ended June 30, 2023"},{"label":"Revenue","value":"$3.5 million"},{"label":"Net income","value":"$0.4 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}